Abstract
The AS03-adjuvanted 2009 pandemic H1N1 influenza vaccine (trade name: PandemrixTM) was associated with an increased risk of narcolepsy in several northern European countries. In other countries where there is a lower prevalence of genetic factors associated with narcolepsy, studies did not find an increase in risk with this vaccine or other influenza vaccines. The vaccine in question (PandemrixTM) was not licensed in the United States, and vaccines in routine use in the United States32F have not been shown to cause narcolepsy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
These conclusions do not consider vaccines recommended only for special populations in the United States such as Yellow Fever vaccine (international travelers) or Smallpox vaccine (military personnel).
References
Nohynek, H., et al., AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One, 2012. 7(3): p. e33536.
Partinen, M., et al., Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One, 2012. 7(3): p. e33723.
Szakacs, A., N. Darin, and T. Hallbook, Increased childhood incidence of narcolepsy in western Sweden after H1N1 influenza vaccination. Neurology, 2013. 80(14): p. 1315–21.
Persson, I., et al., Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up. J Intern Med, 2014. 275(2): p. 172–90.
Johansen, K., The roles of influenza virus antigens and the AS03 adjuvant in the 2009 pandemic vaccine associated with narcolepsy needs further investigation. Dev Med Child Neurol, 2014. 56(11): p. 1041–2.
Dauvilliers, Y., et al., Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France. Brain, 2013. 136(Pt 8): p. 2486–96.
Wijnans, L., et al., The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine, 2013. 31(8): p. 1246–54.
European Centre for Disease Prevention and Control, Narcolepsy in association with pandemic influenza vaccination (a multi-country European epidemiological investigation). ECDC: Stockholm.
Miller, E., et al., Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis. Bmj, 2013. 346: p. f794.
O’Flanagan, D., et al., Investigation of an association between onset of narcolepsy and vaccination with pandemic influenza vaccine, Ireland April 2009-December 2010. Euro Surveill, 2014. 19(17): p. 15–25.
Stowe, J., et al., Risk of Narcolepsy after AS03 Adjuvanted Pandemic A/H1N1 2009 Influenza Vaccine in Adults: A Case-Coverage Study in England. Sleep, 2016. 39(5): p. 1051–7.
Heier, M.S., et al., Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A. Sleep Med, 2013. 14(9): p. 867–71.
Oberle, D., et al., Retrospective multicenter matched case-control study on the risk factors for narcolepsy with special focus on vaccinations (including pandemic influenza vaccination) and infections in Germany. Sleep Med, 2017. 34: p. 71–83.
Feltelius, N., et al., A coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009–2010 Pandemrix vaccination programme in Sweden. J Intern Med, 2015. 278(4): p. 335–53.
Montplaisir, J., et al., Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec. PLoS One, 2014. 9(9): p. e108489.
Partinen, M., et al., Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination. Lancet Neurol, 2014. 13(6): p. 600–13.
McCarthy, N.L., et al., Evaluating the safety of influenza vaccine using a claims-based health system. Vaccine, 2013. 31(50): p. 5975–82.
Tsai, T.F., et al., Explorations of clinical trials and pharmacovigilance databases of MF59(R)-adjuvanted influenza vaccines for associated cases of narcolepsy. Scand J Infect Dis, 2011. 43(9): p. 702–6.
Ahmed, S.S., et al., Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants. J Autoimmun, 2014. 50: p. 1–11.
Duffy, J., et al., Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United States. Neurology, 2014. 83(20): p. 1823–30.
Baxter, R., et al., Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2–49years. Vaccine, 2017. 35(9): p. 1254–8.
Arnheim-Dahlström, L., et al., Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study. BMJ : British Medical Journal, 2013. 347.
Sarkanen, T.O., et al., Incidence of narcolepsy after H1N1 influenza and vaccinations: Systematic review and meta-analysis. Sleep Med Rev, 2018. 38: p. 177–86.
Han, F., et al., Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol, 2011. 70(3): p. 410–7.
Matsuki, K., et al., DQ (rather than DR) gene marks susceptibility to narcolepsy. Lancet, 1992. 339(8800): p. 1052.
Kadotani, H., J. Faraco, and E. Mignot, Genetic studies in the sleep disorder narcolepsy. Genome Res, 1998. 8(5): p. 427–34.
Dye, T.J., N. Gurbani, and N. Simakajornboon, Epidemiology and Pathophysiology of Childhood Narcolepsy. Paediatr Respir Rev, 2016.
Johansen, K., et al., Where are we in our understanding of the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines? Biologicals, 2016. 44(4): p. 276–80.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Dudley, M.Z. et al. (2018). Do Vaccines Cause Narcolepsy?. In: The Clinician’s Vaccine Safety Resource Guide. Springer, Cham. https://doi.org/10.1007/978-3-319-94694-8_46
Download citation
DOI: https://doi.org/10.1007/978-3-319-94694-8_46
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-94693-1
Online ISBN: 978-3-319-94694-8
eBook Packages: MedicineMedicine (R0)